Updates on the adverse events reported in clinical trial in France

It should come as no surprise that there are no quick answers to the question of what, exactly, went wrong in the clinical trial in France in which one participant has died and 5 others experienced other serious adverse events. A few more news articles about the study are here:

An early report in Science

A quick follow-up with some more information in Science

A New York Times story that leaves one very curious about the “three major failings” that are mentioned but not described.